Abstract 4366397: Clinical Outcomes associated with FDA-Labeled and Non-FDA-Labeled Direct Oral Anticoagulant Dosing in US Patients with Atrial Fibrillation, Stratified by Gender: A Real-World Data Study
Year: 2025
Type: conference-abstract
Source: Circulation
Institutions: Ochsner Health System, Bristol-Myers Squibb (United States)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415788920
Cites:
Cited by:
Related to:
